Q-omics provides the consensus-scored PRAMEF31P profile across patient tissues and cancer cell-line models. PRAMEF31P expression is associated with patient survival in 7 of 34 cancer types, with the highest sampling consensus in UCS. Additionally, PRAMEF31P RNA expression shows 6,530 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight UCS, and STAD as cancer lineages where PRAMEF31P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for PRAMEF31P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes PRAMEF31P survival associations across molecular data types. PRAMEF31P RNA expression shows survival associations in the most cancer types (7). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

PRAMEF31P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	7	UCS (144)	view →

This table ranks reproducible PRAMEF31P RNA expression–survival associations across cancer types. High PRAMEF31P expression shows unfavorable associations in UCS, COAD, DLBC, CESC and KIRC, but favorable associations in HNSC. The UCS Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .002). Together, the overview and detailed table identify UCS as the clearest survival context for PRAMEF31P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	IV	0.132	0.718	.002	144	view →
COAD	OS	Tertile	All	0.027	0.871	<.001	36	view →
DLBC	OS	Tertile	III,IV	0.272	1.000	.017	31	view →
CESC	OS	Tertile	III,IV	0.167	0.657	.044	18	view →
KIRC	OS	Tertile	All	0.747	0.813	.017	18	view →
HNSC	DFS	Tertile	All	0.566	0.289	.010	12	view →

Pink = unfavorable, green = favorable. all 7 lineages →

PRAMEF31P-UCS (DFS)

Kaplan–Meier survival curve for PRAMEF31P RNA expression in UCS: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with PRAMEF31P in patient tissues and cancer cell lines. In patient samples, PRAMEF31P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	6,530	STAD (6033)	view →
RNA	5,921	TGCT (1795)	view →